StockGlow

NexImmune, Inc. (NEXI)

Develops injectable cell therapies to train the immune system to fight cancer and blood disorders.

$0.00+0.00%Healthcare
Compare NEXI with
StockGlow Score
21
Leaning Bearish
BearishBullish
1 year ago-50.0%

The outlook

NEXI is trading at its 52-week low with a mixed technical trend. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current market positioning.

What’s behind the score

Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$139
52-wk high
$1.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

PBLAPanbela Therapeutics, Inc.$0.01+0.00%FIEEFiEE, Inc.$2.83-9.84%INABIN8bio, Inc.$1.11-6.72%ABVCABVC BioPharma, Inc.$1.06+3.92%PXMDPaxMedica, Inc.$0.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy